Posted by Michael Wonder on 14 Sep 2022
Potrero Medical receives FDA breakthrough device designation for Accuryn AKI predict algorithm
13 September 2022 - Potrero Medical announced today that the FDA granted breakthrough device designation for their AKI Predict machine learning algorithm, for the advanced prediction of acute kidney injury associated with intra-abdominal hypertension in cardiac post-surgical intensive care patients.
Potrero Medical is a personalised platform transforming patient care through precision fluid management and analytics that offer clinical decision support by providing precise data from the kidney.
